This book provides a timely overview of this important anticancer drug. An introductory chapter includes useful synopses of each of the following chapters. The next four chapters deal with aspects of the chemistry, pharmacology, metabolism and clinical use of tamoxifen and its actions on the oestrogen receptor. Many of these individual topics have been extensively reviewed elsewhere, but it is useful to have them all brought together in one volume. Where appropriate, the author has often prefaced discussion of each topic with a brief general introduction to the biological background. For example the chapter on Metabolism and Toxicology (Chapter 3) begins with a useful summary of the CYP nomenclature used for classifying cytochrome P450 enzymes. The author covers most of the major areas of interest and current controversy. The references at the end of each chapter though not comprehensive, are sufficient to allow the reader to gain entry into the literature of a particular field. These are commendably up to date, some predating publication of the book by only a month or two. An example (p. 27) is a reference to a recent hypothesis that proposes how tamoxifen produces liver DNA adducts.
More than half the book is concerned with apparently oestrogen-independent actions of tamoxifen, the later chapters reflecting the author's personal research interests. This is nevertheless welcome, as it provides a different emphasis from most reviews on this drug. The first of these later chapters describes how tamoxifen modulates certain oncogenes and growth factors. Again there is a simple introduction to oncogenes and the relevant growth factor accompanied by clear diagrams illustrating their functions. This chapter also includes a discussion of mechanisms of resistance. Inhibition of enzymes is the main subject of the following chapter. These include enzymes in cell signalling pathways, such as protein kinase C (PKC), and calmodulin-dependent enzymes. There follows a discussion of the role of the anti-oestrogen binding site (AEBS). A minor criticism here is that the discussion of the structural requirements for ligand binding refers to the work of Van den Koedijk et al. on the rat AEBS. Their later, potentially more relevant, study on the human AEBS shows a different structure-activity relationship.
A discussion of the effect of tamoxifen and 4-hydroxytamoxifen on cholesterol synthesis forms a useful prelude to a following chapter on the antioxidant action of tamoxifen. The first 17 pages of this chapter are a general description of cell membrane structure and function. However, this lengthy introduction is a necessary background to the discussion that follows. In this, the basis thesis is that tamoxifen protects the cell membrane against lipid peroxidation by decreasing membrane fluidity. A variety of beneficial consequences proposed to result from this action include inhibition of metastasis, reversal of the multidrug resistance phenotype and cardio-protection.
The Hempstead, 1995, 440 pp. £112.50. ISBN 0-13-224858-1 This is generally an excellent book giving a thorough treatment to an area of major clinical importance. The editors themselves are well known as excellent researchers in this field but they did not in fact contribute substantially to the writing. They have, however, been able to attract a first class array of writers to cover the subject comprehensively.
The book is divided into four parts with parts 2 and 3 making up about two-thirds of the book: 
